IP15-19: Association Between Glucagon-Like Peptide-1 Agonist Use and Escalation to Surgical Treatment for Benign Prostatic Hyperplasia: A Nationwide Claims Database Study

IP15-19: Association Between Glucagon-Like Peptide-1 Agonist Use and Escalation to Surgical Treatment for Benign Prostatic Hyperplasia: A Nationwide Claims Database Study

Friday, May 15, 2026 1:00 PM to 3:00 PM · 1 hr. 59 min. (America/New_York)

146B

Abstract

Sessions

IP15: Benign Prostatic Hyperplasia: Epidemiology, Evaluation & Medical Non-surgical Therapy

Friday, May 15, 2026 1:00 PM to 3:00 PM

Log in

See all the content and easy-to-use features by logging in or registering!